GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Joincare Pharmaceutical Group Industry Co Ltd (SHSE:600380) » Definitions » Financial Strength

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Financial Strength : 6 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Joincare Pharmaceutical Group Industry Co Financial Strength?

Joincare Pharmaceutical Group Industry Co has the Financial Strength Rank of 6.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

Joincare Pharmaceutical Group Industry Co's Interest Coverage for the quarter that ended in Mar. 2024 was 29.81. Joincare Pharmaceutical Group Industry Co's debt to revenue ratio for the quarter that ended in Mar. 2024 was 0.29. As of today, Joincare Pharmaceutical Group Industry Co's Altman Z-Score is 2.70.


Competitive Comparison of Joincare Pharmaceutical Group Industry Co's Financial Strength

For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joincare Pharmaceutical Group Industry Co's Financial Strength Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Joincare Pharmaceutical Group Industry Co's Financial Strength distribution charts can be found below:

* The bar in red indicates where Joincare Pharmaceutical Group Industry Co's Financial Strength falls into.



Joincare Pharmaceutical Group Industry Co Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Joincare Pharmaceutical Group Industry Co's Interest Expense for the months ended in Mar. 2024 was ¥-34 Mil. Its Operating Income for the months ended in Mar. 2024 was ¥1,006 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥2,355 Mil.

Joincare Pharmaceutical Group Industry Co's Interest Coverage for the quarter that ended in Mar. 2024 is

Interest Coverage=-1*Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*1005.645/-33.733
=29.81

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Joincare Pharmaceutical Group Industry Co's Debt to Revenue Ratio for the quarter that ended in Mar. 2024 is

Debt to Revenue Ratio=Total Debt (Q: Mar. 2024 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2757.638 + 2354.699) / 17359.256
=0.29

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Joincare Pharmaceutical Group Industry Co has a Z-score of 2.70, indicating it is in Grey Zones. This implies that Joincare Pharmaceutical Group Industry Co is in some kind of financial stress. If it is below 1.81, the company may faces bankrupcy risk.

Warning Sign:

Altman Z-score of 2.7 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Joincare Pharmaceutical Group Industry Co  (SHSE:600380) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Joincare Pharmaceutical Group Industry Co has the Financial Strength Rank of 6.


Joincare Pharmaceutical Group Industry Co Financial Strength Related Terms

Thank you for viewing the detailed overview of Joincare Pharmaceutical Group Industry Co's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Joincare Pharmaceutical Group Industry Co (SHSE:600380) Business Description

Traded in Other Exchanges
N/A
Address
No. 17 Langshan Road, Joincare Pharmaceutical Group Building, Nanshan New and High-Tech Industrial Development (, Shenzhen, Guangdong, CHN, 518057
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
Executives
Yu Xiong Directors, senior managers
Zhao Feng Guang senior management
Qiu Qing Feng Directors, senior managers
Tang Ling Zhi senior management
Lin Nan Qi Directors, senior managers
Cao Ping Wei Director
Feng Yan Fang Director
Zhong Shan senior management
Yang Dong Yun senior management
Peng Jin Hua Supervisors
Xie You Guo Supervisors
Guo Xiao Yun Supervisors
Su Qing Wen senior management

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Headlines

No Headlines